The EGCG-treated colorectal-cancer cells demonstrated the cleavage of protein Caspase-3 and PARP in a dose-dependent manner, indicating the apoptosis-induction effects of EGCG in SW480, SW620, and LS411N cells (Figures 5–7A and B). The gene discussed is CASP3; the disease is colorectal cancer.